GlaxoSmithKline (GSK.L) News and Pharmaceutical & Healthcare Updates

1,890
0.00
0.00 %
Daily range
Weekly range
  • Daria Chernytska
  • 06.11.2026
GSK and Moderna settle vaccine patent dispute across U.S. and Europe
The agreement closes a cross-border patent fight over mRNA vaccine technology that had added to a broader web of litigation in the sector. The settlement covers Moderna's COVID-19 shots Spikevax ...
  • Sholanke Dele
  • 06.11.2026
GSK stock extends lower as sellers maintain control over price action
GSK (GSK) stock is trading at GBX1,846.00, marking a daily decline of 2.33%. The price currently sits below its major moving averages, reflecting ongoing pressure in the ...
  • Viktoras Karapetjanc
  • 06.11.2026
GSK shares fall over 2% as intraday selling pressures and fading momentum weigh on price
GSK plc (GSK) fell 2.01% as intraday selling pressured the shares, with buyers unable to sustain early gains amid cautious sentiment and fading momentum. The move is limited by the stock holding ...
  • Viktoras Karapetjanc
  • 05.11.2026
GSK trades flat as buyer support persists in a mixed technical setup
GSK (GSK) stock is trading at GBX1,892.50 with a slight gain for the session. The price currently sits above its key short- and medium-term moving averages, suggesting ...
  • Viktoras Karapetjanc
  • 04.11.2026
GSK shares gain about 1.5% after strong technical momentum boosts session highs
GSK plc (GSK) advanced 1.59% on strong short- and medium-term technical momentum, as buyers drove the stock toward session highs. The move is supported by the price crossing above both the 20-day ...
  • Sergey Shendetskyi
  • 04.11.2026
GSK drops as downward price move intensifies
GSK (GSK) stock is trading at GBX1,808, down 1.09% on the day. The price remains below its key moving averages, reflecting persistent downward ...
  • Mykhailo Ihnatenko
  • 03.11.2026
Will GSK stock hold above GBX1,833 support amid seller pressure and weak momentum?
GSK (GSK) stock is trading at GBX1,836.50, reflecting a modest intraday rise. The price remains below its key moving averages, indicating pressure relative to recent ...
  • Hlib Chabaniuk
  • 02.11.2026
GSK trades flat as buyers defend GBX1,830 support
GSK (GSK) stock is trading at GBX1,837 after a modest move lower today. The price sits above its key short-term moving averages but remains beneath the medium- and ...
  • Oleg Tkachenko
  • 30.10.2026
What's behind GSK's latest 2.3% stock surge?
GSK plc (GSK) surged 2.29% after its third-quarter 2026 results pointed to steady sales growth and maintained earnings guidance, fueling renewed buying interest in the shares. The move finds ...
  • Dmytro Kharkov
  • 30.10.2026
GSK PLC beats earnings and confirms dividend: Can GSK stock sustain recent gains?
GSK (GSK) stock is trading at GBX1,838.50, up 1.35% on the day. The price is positioned above its key short-term moving averages but remains below medium- and ...
  • Mira Kyivska
  • 29.10.2026
What's behind GSK's latest 1.5% stock pullback?
GSK plc (GSK) slid 1.5% after reporting third-quarter earnings including steady sales growth and reaffirmed full-year guidance, with sellers dominating early trade. The decline is supported by the ...
  • Oleg Tkachenko
  • 29.10.2026
GSK stock falls as weak momentum persists
GSK (GSK) stock is trading at GBX1,801.50, down 1.15% on the day. The price remains below its key moving averages, pointing to ongoing weakness in the current ...
  • Anastasiia Chabaniuk
  • 28.10.2026
London stocks slip as Unilever, GSK results weigh on FTSE 100
London equities are trading cautiously on Wednesday as investors assess corporate earnings and await the UK budget and the U.S. Federal Reserve's rate decision. The FTSE 100 is down 0.3% by ...
  • Sholanke Dele
  • 28.10.2026
GSK stock forecast: Downside risk mounts as bearish momentum dominates
GSK (GSK) stock is trading at GBX1,820, down 5.16% on the day. The price has moved below its key short-, medium-, and long-term moving ...
  • Andrey Mastykin
  • 28.10.2026
What's behind GSK's latest 4.2% stock pullback?
GSK plc (GSK) slumped 4.22% today after a downside gap, even as the company delivered solid third-quarter results and raised its dividend. The move is supported by a bearish technical structure, ...
  • Mykhailo Ihnatenko
  • 27.10.2026
GSK stock trades sideways as overbought conditions and buyer support balance near GBX1,895
GSK (GSK) stock is trading at GBX1,911.50 after a modest slip in the latest session, exhibiting a slight decline for the day. The current price sits above its short- and ...
  • Ezequiel Gomes
  • 26.10.2026
GSK stock holds steady amid consolidation near a key level
GSK (GSK) stock is trading at GBX1,909.50, up modestly for the session. The price currently sits above its key short- and medium-term moving averages, suggesting a ...
  • Ivan Andriyenko
  • 23.10.2026
GSK stock falls around 1.5% as profit pressure weighs on net margin
GSK plc (GSK) fell 1.59% after a day marked by profit pressure, as the company reported higher revenue but saw its net margin sharply reduced. The move is further supported by the technical ...
  • Ciaran Ryan
  • 23.10.2026
Will GSK stock avoid deeper losses amid overbought technical signals?
GSK (GSK) stock is trading at GBX1,890, posting a daily loss of 1.41%. Shares are positioned above their key short- and medium-term moving averages while remaining below ...
  • Viktoras Karapetjanc
  • 22.10.2026
Why is GSK stock up 1.6% today?
GSK plc (GSK) advanced 1.63% after receiving US regulatory approval for its cancer drug Jemperli, which drew renewed buyer interest into the session. The up move is supported by technical momentum ...
  • Jainam Mehta
  • 22.10.2026
GSK plc receives US approval for Jemperli and reports positive R&D update: Can GSK regain momentum?
GSK (GSK) stock is trading at GBX1,873 after a modest pullback in today’s session. The price remains above its short- and medium-term moving averages while holding ...